| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eede0d66f84b59aba7268d0580262eba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3808fee410832ba4b057832e6a2e44a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_830e860a82ddf7d8b19cc3abfc813b4b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 |
| filingDate |
1982-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_332a469972abe4f8a7b4df5534a012da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbd53f7cbb5e6ddd5719fefac11511af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81fb90fdf97052fdfb3384d4059b5315 |
| publicationDate |
1982-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-8203408-A1 |
| titleOfInvention |
Method for the preparation of a dna-hybride,containing the complementary genome of the hepatitis a virus,the dna-hybride itself,the plasmic vector contain it,the specific proteins of the virus coded by the dna-hybride and vaccins containing them |
| abstract |
Process for the preparation of a hybrid DNA, containing the complementary genome characteristic of the hepatitis A virus, then also the hybrid DNA obtained by this process, then the plasmid vector containing it, then also the proteins and protein-hybrids transcribed in bacterial clones, then also the use of this DNA-hybrid in the diagnosis of hepatitis A virus in a biological sample and finally the invention also relates to vaccines, containing such proteins or protein-hybrids. |
| priorityDate |
1981-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |